GASTON-DREYFUS REMI reported 1 transaction at BIONIK LABORATORIES CORP.
Review the transaction codes below to understand the nature of each event.
Filed: 6/21/2023ACC: 0001104659-23-073232
Director10% Owner
Since Jul 2018
+3.10M
Net shares
Net buyer
$1.86M
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3.10M acquired
Non-Derivative Transactions1
Common Stock, par value $0.001 per share
Indirect
Shares
+3.10M
Price / share
$0.60
Trade value
$1.86M
% of position
171.0%
6/13/2023
1.81M→4.92M
Total
Net shares
+3.10M
Net value
$1.86M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 6/13/2023 | C · Conversion | +3.10M | $0.60 | $1.86M | 171.0% | 1.81M | 4.92M |
| Total | +3.10M | $1.86M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, par value $0.001 per share
DirectShares owned61.26K
Total
61.26K direct61.26K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 per share | 61.26K | Direct |
| Total | 61.26K | 61.26K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported